187 filings
ARS
2023 FY
BIOR
Biora Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:11pm
DEFA14A
BIOR
Biora Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:06pm
DEF 14A
BIOR
Biora Therapeutics Inc
Definitive proxy
24 Apr 24
4:01pm
EFFECT
BIOR
Biora Therapeutics Inc
18 Apr 24
Notice of effectiveness
12:15am
PRE 14A
BIOR
Biora Therapeutics Inc
Preliminary proxy
12 Apr 24
4:30pm
8-K
623 a1pinz
2 Apr 24
Entry into a Material Definitive Agreement
4:48pm
424B5
egeye
2 Apr 24
Prospectus supplement for primary offering
4:46pm
424B5
ws1lxvcr zy1w99cjl
2 Apr 24
Prospectus supplement for primary offering
4:44pm
424B5
xklx40
2 Apr 24
Prospectus supplement for primary offering
4:41pm
424B5
hfgiflz9jj7c45q3dlns
2 Apr 24
Prospectus supplement for primary offering
4:40pm
424B5
vdpe s3sqyxrx2pkb3jl
2 Apr 24
Prospectus supplement for primary offering
4:37pm
424B5
io5qxrtg wyz
2 Apr 24
Prospectus supplement for primary offering
4:35pm
424B5
f2hp mqhhbpb
1 Apr 24
Prospectus supplement for primary offering
4:02pm
8-K
ugnx9bsar
26 Mar 24
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
4:10pm
8-K
6jjnr48aobkm2y4mz0l8
11 Mar 24
Entry into a Material Definitive Agreement
8:11am
8-K
49xizawc
16 Jan 24
Biora Therapeutics Provides Outlook for 2024
5:20pm
EFFECT
5jy 8u700a
2 Jan 24
Notice of effectiveness
12:15am
CORRESP
l6ycy7t
27 Dec 23
Correspondence with SEC
12:00am